See the pitch deck that Compass Pathways used to raise $80 million and fuel its rise into one of the world's biggest psychedelics companies · page 10 of 28
The table provides a quantitative comparison of clinical trial characteristics for BTD vs non-BTD pathways, highlighting the efficiency gains.
Pitch deck · why_now · argue_timing · overcrowded density
Slide locked Sign in to view
Slide schematic 5/7
callout 0/1 list 1/1 metric 0/1 paragraph 1/1 source-note 1/1 table 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 7
callout bullet primary paragraph source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.